India

Over the years, INTERMED has established a wide marketing network in the Eastern, Northern and Western parts of India.

The set-up is supplemented by a wide distribution network in all activities which are centered on establishing the company's brands in respective markets for sustained sales.

The company's basket contains antibiotics, Gastrointestinal drugs, analgesics, NSAIDs, Topical preparations ,anti-diahorreals and anti-infective and anti-protozoals.

We have now built a strong product platform and will continue to add more products and more markets in a phased manner in the near future.

 

International markets

INTERMED ‘s objective is in delivering world-class products and has earned it reputable presence in over 32+ countries on the International Pharmaceutical Horizon with 400+ product registrations.

With the objective of building sustainable and scalable business model, we have been continuously filing product registration dossiers in different countries in various therapeutic segments. Besides gaining market share from existing products, new product launches which are awaiting approvals will ensure sustained growth in years to come.

We want to unite globally with you all under a shared vision and mission on a compatible and well laid out business strategy with long term perspective to bring in prosperity to all.

We have developed over 300 products with ENGLISH/FRENCH/SPANISH AND PORTUGUESE CONTENTS AND TEXT MATTERS and this in-built strength gives us leverage to expand to other Countries with minimal lead time.

 

Horizon 2014-2020

Focus Markets –Developing World

The most common markets for INTERMED product include the following countries. Please inquire with us if your country or region is not listed:

Africa: Nigeria, Niger, Mali, Ghana, Burkina Faso, Benin, Togo, Cameroon, Gabon, Angola, Sierra Leone, Liberia, Senegal, Ivory Coast,Conakry, Guinea, Kenya, Ethiopia, Congo, Mozambique, Zambia, Zimbabwe, Rwanda, Malawi, Central Africa Republic, Somalia, Burundi, Tanzania, Namibia.

Asia: Vietnam, Philippines, Cambodia, Laos, Myanmar, Kyrgyzstan, Kazakhstan, Azerbaijan, Uzbekistan, Fiji, Papua New Guinea and surrounding islands around Fiji.

South America: Peru, Ecuador, Bolivia, Columbia, Venezuela, Guatemala, El Salvador, Costa Rica, Panama, Belize, Nicaragua, Honduras, Cuba, Haiti, Ecuador, Dominican Republic ,Bahamas, Barbados, Jamaica, Trinidad & Tobago, Chile, Guyana.

International Plant Approvals

Currently Intermed's manufacturing facilities are approved by the following authorities:

• WHO-GMP
• DPM - IVORY COAST
• NAFDAC -NIGERIA
• DIGEMED-PERU
• CECMED -CUBA
• MOH-CONGO
• PPB-KENYA

 

Intermed Has Registered And Supplied Medicines To The Following Countries:

1. EUROPE : Russia & Moldova.
2. SOUTH AMERICA : Peru , Venezuela , Ecuador , Guyana , Suriname.
3. CENTRAL AMERICA : Guatemala , El Salvador , Nicaragua , > Costa Rica and Honduras.
4. CARIBBEAN COUNTRIES : Cuba , Dominican Republic , Jamaica .
5. AFRICA : South Africa , Nigeria , Mozambique , Kenya, DR CONGO , Malawi , Zambia , Burkina Faso , Mali, Mauritius , Cameroon , Conakry, Guinea , Burundi , Angola , Ivory Coast , Rwanda.
6. AUSTRALASIA : Fiji & Papua New Guinea
7. ASIA : Myanmar , Sri Lanka , Vietnam